Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration.
We describe a 63-year-old man with a 5-year history of progressive sporadic olivopontocerebellar atrophy (OPCA) who exhibits high serum titers of IgM autoantibodies to the neuronal glutamate receptor subunit GluR2. Immunohistochemistry revealed intense staining of mouse cerebellar Purkinje cells and cells in the pontine nuclei and olivary complex. Glutamate receptor currents were activated in a subset of cultured mouse neurons by an anti-GluR2 IgM fraction, and they were blocked by the competitive AMPA-type glutamate receptor antagonist CNQX and by a synthetic peptide to a specific epitope region of GluR2 (AA 369-393). The patient was treated with nine courses of plasmapheresis with little improvement of symptomatology. However, IgM titers to GluR2 decreased approximately 8-fold and the serum functional activity decreased proportionally. These findings may suggest a role for autoimmunity to glutamate receptors in the pathophysiology of certain forms of progressive nervous system degeneration.
Gahring
L C
LC
Geriatric Research, Education and Clinical Center (GRECC), VA Medical Center, Salt Lake City, UT 84112, USA.
Rogers
S W
SW
Twyman
R E
RE
D000818:Animals; D001323:Autoantibodies / Q000032:analysis*; D002540:Cerebral Cortex / Q000503:physiopathology; D004594:Electrophysiology; D018604:Epitope Mapping; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008875:Middle Aged; D009474:Neurons; D009849:Olivopontocerebellar Atrophies / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy; D010956:Plasmapheresis; D018091:Receptors, AMPA / Q000276:immunology*; D017470:Receptors, Glutamate / Q000276:immunology*
D001323:Autoantibodies; D018091:Receptors, AMPA; D017470:Receptors, Glutamate; C104722:glutamate receptor ionotropic, AMPA 2